Transactions - Asian Capital

Mergers and Acquisitions

Restructuring and Resumption of Trading

Financial Advisory

Fund Raising and IPO

Type

Industry

Freeman Corporation Limited

Stock Code: 279
Announcement Date: 10 December, 2008
Deal Size (HK$): 105.8 Million
Status: Closed

Very substantial acquisition

China Sciences Conservational Power Limited

Stock Code: 351
Announcement Date: 30 July, 2008
Deal Size (HK$): 375 Million
Status: Closed

(1) Subscription of Shares and Convertible Bonds as connected transactions, Special Deal; (2)Whitewash Waiver application; (3) placing of Placing Shares; (4) Group Reorganization; (5) adoption of New Share Option Scheme; and (6) termination of Existing Share Option Scheme

Beauforte Investors Corporation Limited

Stock Code: 21
Announcement Date: 12 June, 2008
Deal Size (HK$): 78.4 Million
Status: Closed

Very substantial acquisition in relation to the Acquisition of the Sale Shares and the Loan

United Gene High-Tech Group Limited (formerly known as Far East Pharmaceutical Technology Company Limited)

Stock Code: 399
Announcement Date: 28 May, 2008
Deal Size (HK$): 60 Million
Status: Closed

Restructuring of Far East Pharmaceutical Technology Company Limited (Provisional Liquidators Appointed) involving, inter alia, proposed Capital Restructuring, creditors' scheme of arrangement in accordance with section 166 of the Companies Ordinance, Subscription of Subscription Shares and ADM Subscription Shares, placing of Placing Shares, Whitewash Waiver and General Mandates to issue and repurchase Shares

Dickson Group Holdings Limited (in liquidation)

Stock Code: 313
Announcement Date: 31 March, 2008
Deal Size (HK$): 741.2 Million
Status: Closed

Restructuring of Dickson Group Holdings Limited (In Liquidation) involving, inter alia, creditors' schemes of arrangement in accordance with section 99 of the Companies Act and section 166 of the Companies Ordinance, Subscription of the Subscription Shares and the Convertible Notes, disposal of the Disposed Companies as a very substantial disposal, the DG Options as a discloseable transaction, increase in authorised share capital, issue of New Shares under Specific Mandates and Whitewash Waiver